Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Foie Gras

Financiado

Cerrado

Bioenergetic Remodeling in the Pathophysiology and Treatment of Non Alcoholic Fa...

Bioenergetic Remodeling in the Pathophysiology and Treatment of Non Alcoholic Fatty Liver Disease FOIE GRAS provides innovative training for 13 early stage researchers (ESRs) to answer two critical and unanswered questions: a) Is hepatic bioenergetic remodelling involved in NAFLD pathogenesis, and target for stratification or... ver más

30/06/2021

CNC

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASS... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 15 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-06-30

MSCA-ITN-2016: Innovative Training Networks

I+D

Cerrada hace 9 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

15 Participantes

CNC

476.71K€ | Lider

INCOM - INGENIERIA DE COMPUE...

213.33K€ | Participante

Cetics Healthcare Technologi...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

halt-RONIN Discovering chronic inflammation biomarkers that define key... 7M€ Cerrado

BARINAFLD Using Bariatric Surgery to Discover Weight Loss Independent... 1M€ Cerrado

mtFOIE GRAS mitoFOIE GRAS Non invasive Profiling of Mitochondrial Funct... 455K€ Cerrado

SAF2017-85877-R INVESTIGACION TRASLACIONAL EN ESTEATOHEPATITIS NO ALCOHOLICA... 182K€ Cerrado

LITMUS Liver Investigation Testing Marker Utility in Steatohepatit... 47M€ Cerrado

PID2021-126096NB-I00 REMODELACION DEL METABOLISMO DE GLUCOSA Y LIPIDOS EN CELULAS... 424K€ Cerrado

Duración del proyecto: 58 meses Fecha Inicio: 2016-08-29
Fecha Fin: 2021-06-30

Líder del proyecto

CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASS... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto FOIE GRAS provides innovative training for 13 early stage researchers (ESRs) to answer two critical and unanswered questions: a) Is hepatic bioenergetic remodelling involved in NAFLD pathogenesis, and target for stratification or therapeutic/lifestyle interventions? and b) Is the disruption of the gut-liver axis involved in NAFLD progression? In Western Societies, there has been a recent surge of non-alcoholic fatty liver disease (NAFLD). Its progression to nonalcoholic steatohepatitis (NASH) is a leading risk factor for development of Type 2 diabetes, cirrhosis, and hepatocellular carcinoma. FOIE GRAS is first in supporting a cohesive and synergistic intersection of complementary and interdisciplinary training skills from academic and non-academic partners. FOIE GRAS combines strong scientific expertise with integrated and complementary training in translational research, clinical practice, technology commercialization, and public outreach, the combination of which in targeting NAFLD is lacking in the EU. Industrial partners CETICS, Mediagnost and Seahorse Biosciences provide experience on technology commercialization alongside scientific contributions while the affiliated patient organization will contribute with important training in societal awareness topics. ESRs training will utilize network-wide workshops and secondments to foster translation of basic research to clinical applications and SME creation. This diverse yet integrated skill set enhances the employment prospects of the trained researchers in both academic and non-academic sectors. Researchers will be endowed with excellent basic scientific knowledge and timely technology transfer know-how for developing novel therapeutic approaches for reversing the burden of NAFLD, thereby advancing both health and economic well-being of European citizens and approaching NAFLD research in the EU from its counterparts in the US and Asia.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores